TNXPTonix Pharmaceuticals Holding Corp
TNXP
Tonix Pharmaceuticals Holding Corp82,271
Mkt Cap
$232.59MVolume
291,865.0052W High
$130.0052W Low
$6.76PE Ratio
-0.02TNXP Fundamentals
Price
$19.63Prev Close
$19.75Open
$19.7450D MA
$18.62Beta
1.29Avg. Volume
815,811.42EPS (Annual)
-$17,659.80P/B
0.86Rev/Employee
$124,617.28Equities Analysts Offer Predictions for TNXP FY2025 Earnings
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) - Equities research analysts at Zacks Small Cap raised their FY2025 earnings per share estimates for Tonix Pharmaceuticals in a report...
MarketBeat·15h ago
Tonix Pharmaceuticals (NASDAQ:TNXP) Announces Quarterly Earnings Results
Tonix Pharmaceuticals (NASDAQ:TNXP - Get Free Report) released its quarterly earnings results on Monday. The company reported ($3.59) earnings per share (EPS) for the quarter, hitting the consensus...
MarketBeat·1mo ago
Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic
The late-stage candidate TNX-102 SL has received FDA Fast Track status and has delivered positive results in two pivotal Phase 3 trials, demonstrating meaningful pain reduction.
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive
In his role at Celgene Corp, Hand played a strategic role in transactions including the $74 billion acquisition of Celgene by Bristol Myers Squibb and its subsequent integration.